Concepedia

Author

Annika Allqvist

Karolinska University Hospital

Also Known As

A Allqvist, A. Allqvist, Annika Allqvist

9

Publications

369

Citations

6

H-Index

15

Concepts

All Affiliations

Karolinska University HospitalKarolinska InstitutetMuhimbili University of Health and Allied Sciences
AA

About

Annika Allqvist is an author at Karolinska University Hospital specializing in pharmacology, medicine, and drug analysis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

74

2

Pharmacology

3

3

74

3

Clinical Chemistry

1

1

20

4

Drug Monitoring

1

1

18

5

Mass Spectrometry

1

1

20

Annika Allqvist

×

6

Publications

368

Citations

6

H-Index

YearCitations

4β-Hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians

Ulf Diczfalusy, Jun Miura, Hyung‐Keun Roh,

Pharmacogenetics and Genomics

2008

145

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population

Rajaa A. Mirghani, Jane Sayi, Eleni Aklillu,

Pharmacogenetics and Genomics

2006

86

CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir

Filip Josephson, Annika Allqvist, Mohamed Janabi,

Clinical Pharmacology & Therapeutics

2007

63

Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers

Annika Allqvist, Jun Miura, Leif Bertilsson,

European Journal of Clinical Pharmacology

2007

36

Simultaneous quantification of alprazolam, 4- and α-hydroxyalprazolam in plasma samples using liquid chromatography mass spectrometry

Annika Allqvist, Agneta Wennerholm, Jan‐Olof Svensson,

Journal of Chromatography B

2004

20

Alprazolam as a probe for CYP3A using a single blood sample: pharmacokinetics of parent drug, and of α- and 4-hydroxy metabolites in healthy subjects

Agneta Wennerholm, Annika Allqvist, Jan‐Olof Svensson,

European Journal of Clinical Pharmacology

2005

18

Page 1